A Single Center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment - A Phase I Study.
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Oshadi D (Primary) ; Oshadi R (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 20 Jun 2012 Actual patient number is 7 as reported by ClinicalTrials.gov.
- 20 Jun 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.